Comparison of different CDK4/6 Kinase Inhibitors (Palbociclib, Ribociclib, Abemaciclib) and their Influence on the Effectiveness of simultaneous Radiation Therapy

Jost T, Hecht M, Fietkau R, Distel L (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Strahlentherapie und Onkologie Urban & Vogel

Publisher: SPRINGER HEIDELBERG

City/Town: HEIDELBERG

Pages Range: S193-S193

Conference Proceedings Title: STRAHLENTHERAPIE UND ONKOLOGIE

Event location: Weisbaden DE

Authors with CRIS profile

Tina Jost Department of Radiation Oncology Markus Hecht Department of Radiation Oncology Rainer Fietkau Lehrstuhl für Strahlentherapie Luitpold Distel Department of Radiation Oncology

How to cite

APA:

Jost, T., Hecht, M., Fietkau, R., & Distel, L. (2020). Comparison of different CDK4/6 Kinase Inhibitors (Palbociclib, Ribociclib, Abemaciclib) and their Influence on the Effectiveness of simultaneous Radiation Therapy. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S193-S193). Weisbaden, DE: HEIDELBERG: SPRINGER HEIDELBERG.

MLA:

Jost, Tina, et al. "Comparison of different CDK4/6 Kinase Inhibitors (Palbociclib, Ribociclib, Abemaciclib) and their Influence on the Effectiveness of simultaneous Radiation Therapy." Proceedings of the 26th Annual Conference of the German-Society-for-Radiation-Oncology (DEGRO), Weisbaden HEIDELBERG: SPRINGER HEIDELBERG, 2020. S193-S193.

BibTeX: Download